Discover
AKBA
Akebia Therapeutics, Inc.
0.71
2 x 0.50
2 x 0.92
bid
ask
-
0.04
4.81%
2 @ 04:00 PM
0.71 +0.00 (0.00%)
| Ytd | -56.12% | |
| 1y | -66.36% |
0.70
day range
0.73
0.54
52 week range
2.23
| Open | 0.72 | Prev Close | 0.74 | Low | 0.70 | High | 0.73 | Mkt Cap | 195.78M |
| Vol | 2.77M | Avg Vol | 7.83M | EPS | -0.12 | P/E | N/A | Forward P/E | -7.15 |
| Beta | 0.73 | Short Ratio | 4.71 | Inst. Own | 27.33% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 0.85 | 200-d Avg | 1.15 | 1yr Est | 5.50 |
| Income Statement | |||
| Total Revenue | 49.13M | ||
| Revenues (USD) | 49.13M | ||
| Cost of Revenue | 10.42M | ||
| Gross Profit | 38.70M | ||
| Operating Expenses | 44.18M | ||
| Research and Development Expense | 14.06M | ||
| Selling, General and Administrative Expense | 28.17M | ||
| Operating Income | -5.47M | ||
| Interest Expense | 3.07M | ||
| Income Tax Expense | 70.00K | ||
| Net Income | -8.91M | ||
| Net Income Common Stock | -8.91M | ||
| Net Income Common Stock (USD) | -8.91M | ||
| Consolidated Income | -8.91M | ||
| Earnings per Basic Share | -0.03 | ||
| Earnings per Basic Share (USD) | -0.03 | ||
| Earnings per Diluted Share | -0.03 | ||
| Earning Before Interest & Taxes (EBIT) | -5.77M | ||
| Earning Before Interest & Taxes (USD) | -5.77M | ||
| Weighted Average Shares | 269.60M | ||
| Weighted Average Shares Diluted | 269.60M | ||
| Balance Sheet | |||
| Cash and Equivalents | 155.55M | ||
| Cash and Equivalents (USD) | 155.55M | ||
| Trade and Non-Trade Receivables | 53.51M | ||
| Current Assets | 229.55M | ||
| Property, Plant & Equipment Net | 7.31M | ||
| Total Assets | 349.66M | ||
| Debt Current | 24.81M | ||
| Total Debt | 53.96M | ||
| Current Liabilities | 160.87M | ||
| Debt Non-Current | 29.15M | ||
| Total Liabilities | 324.64M | ||
| Accumulated Retained Earnings (Deficit) | -1.70B | ||
| Accumulated Other Comprehensive Income | 6.00K | ||
| Shareholders Equity | 25.02M | ||
| Shareholders Equity (USD) | 25.02M | ||
| Assets Non-Current | 120.11M | ||
| Total Debt (USD) | 53.96M | ||
| Deferred Revenue | 6.17M | ||
| Goodwill and Intangible Assets | 59.04M | ||
| Inventory | 13.02M | ||
| Liabilities Non-Current | 163.78M | ||
| Trade and Non-Trade Payables | 9.42M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.81M | ||
| Net Cash Flow from Financing | -6.54M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -7.09M | ||
| Capital Expenditure | -1.08M | ||
| Net Cash Flow - Business Acquisitions and Disposals | -3.00M | ||
| Issuance (Purchase) of Equity Shares | 3.33M | ||
| Issuance (Repayment) of Debt Securities | -1.50M | ||
| Net Cash Flow from Investing | -4.08M | ||
| Net Cash Flow from Operations | 3.53M | ||
| Share Based Compensation | 3.23M | ||